Health care startups that raised Series A in DACH
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cellbox Solutions | Cologne | Series A | $1.7M | 2026-10-20 |
| SOMAREALITY | Vienna | Series A | $3.4M | 2026-06-18 |
| mbiomics | Munich | Series A | $12.0M | 2026-04-28 |
| Rivia | Zürich | Series A | $15.0M | 2026-03-18 |
| RAYDIAX | Magdeburg | Series A | $5.9M | 2026-03-01 |
| nyra health | Vienna | Series A | $23.6M | 2026-02-24 |
| Leman Biotech | Lausanne | Series A | $28.8M | 2026-01-26 |
| Altavo | Dresden | Series A | $3.5M | 2026-01-22 |
8 rows of the CSV in 5 of its 18 columns.
- The 240 health care startups in DACH whose last round is Series A have raised $1.9B in total.
- 16 of them closed their most recent round in the last 12 months, $174.7M combined.
- The largest of those rounds is Leman Biotech's $28.8M Series A, dated January 2026.
- The most recent is Cellbox Solutions' $1.7M Series A on 20 October 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 21 of them, more than any other fund.
- Biotech is the most common other sector, with 102 companies (42%).
- 15% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (52% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 240| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| SOMAREALITY | SOMAREALITY develops spatial computing and eye tracking technology to measure cognitive digital biomarkers. | Education | Vienna, Austria | Series A | $3.4M | 2026-06-18 | $8.4M | Startup Wise Guys, The Austrian Research Promotion Agency (FFG), Gateway Ventures +2 | 11 to 50 | 2019 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich, Germany | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich, Switzerland | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg, Germany | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| Altavo | Altavo develops medical devices as a startup. | Health care | Dresden, Germany | Series A | $3.5M | 2026-01-22 | $8.9M | HTGF (High-Tech Gruenderfonds), TGFS - Technologiegründerfonds Sachsen, bm-t beteiligungsmanagement thuringen +2 | 11 to 50 | 2021 |
| HEY HOLY | HEY HOLY sells breed-specific dog food through subscriptions. | Health care | Mannheim, Germany | Series A | $6.6M | 2025-07-16 | $9.8M | Slingshot Ventures | 11 to 50 | 2022 |
| Comphya | Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. | Biotech | Lausanne, Switzerland | Series A | $4.0M | 2025-07-08 | $14.2M | Venture Kick, Verve Ventures, Nest Collective Foundation | 1 to 10 | 2017 |
| Rhygaze | Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. | Biotech | Basel, Switzerland | Series A | $86.0M | 2025-01-10 | $97.3M | Google Ventures, F-Prime, ARCH Venture Partners +2 | 11 to 50 | 2024 |
| Lyfegen | Lyfegen provides SaaS rebate management software for the healthcare industry. | Fintech | Basel, Switzerland | Series A | $5.7M | 2024-12-11 | MassChallenge, Innosuisse, APEX Ventures +1 | 51 to 100 | 2018 | |
| invIOs | invIOs is a private biotech company that discovers and develops cancer therapies. | Biotech | Vienna, Austria | Series A | $8.9M | 2024-10-15 | $12.9M | The Austrian Research Promotion Agency (FFG), Ligand Pharmaceuticals | 11 to 50 | 2019 |
| Mindpeak | Mindpeak develops AI-based diagnostic software that detects, quantifies, and classifies cancer. | Artificial intelligence | Hamburg, Germany | Series A | $15.3M | 2024-09-30 | European Innovation Council, EIC Accelerator, Nina Capital +2 | 11 to 50 | 2018 | |
| Vandria | Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders. | Health care | Lausanne, Switzerland | Series A | $10.1M | 2024-08-21 | Innosuisse, Dolby Family Ventures, Eurostars +1 | 1 to 10 | 2021 | |
| PL BioScience | PL BioScience delivers 2D and 3D cell culture solutions based on human Platelet Lysate. | Biotech | Aachen, Germany | Series A | $8.5M | 2024-08-08 | $13.0M | TechVision Fund, better ventures, Brightlands Venture Partners +1 | 11 to 50 | 2015 |
| deepc | deepc provides an AI operating system for radiology. | Artificial intelligence | Munich, Germany | Series A | $13.0M | 2024-07-25 | $26.0M | VentureOut, Sofinnova Partners, Bertelsmann Investments +2 | 11 to 50 | 2019 |
| apoQlar | apoQlar uses mixed reality to support surgical care and medical education. | Health care | Hamburg, Germany | Series A | $10.8M | 2024-05-05 | $10.8M | IFB Innovationsstarter, YZR Capital | 51 to 100 | 2017 |
| Neurosterix | Neurosterix is a biopharmaceutical firm creating allosteric modulators for neurological illnesses. | Biotech | Geneva, Switzerland | Series A | $65.0M | 2024-04-03 | $65.0M | Perceptive Advisors, Xontogeny, Acorn Bioventures | 11 to 50 | 2024 |
| Spirecut | Spirecut makes ultrasound-guided instruments that make minimally invasive surgery widely accessible. | Health care | Muttenz, Switzerland | Series A | $800K | 2024-03-26 | $2.2M | Innovate UK, MassChallenge Switzerland, Innosuisse +1 | 1 to 10 | 2020 |
| Scailyte | Scailyte delivers precision medicine through single-cell science. | Artificial intelligence | Basel, Switzerland | Series A | $1.8M | 2023-12-04 | $15.6M | Venture Kick, Verve Ventures, Innosuisse +2 | 11 to 50 | 2017 |
| mybacs | mybacs is a research-driven direct-to-consumer company specializing in the human microbiome. | Commerce | Zug, Switzerland | Series A | $5.9M | 2023-10-19 | Global Founders Capital, Social Starts, Joyance Partners +2 | 51 to 100 | 2019 | |
| TOLREMO therapeutics | TOLREMO therapeutics develops small molecules that target drug resistance pathways in cancer therapy. | Biotech | Zürich, Switzerland | Series A | $37.9M | 2023-09-20 | Altos Ventures, redalpine, BioMedPartners +1 | 11 to 50 | 2017 | |
| Mammaly | Mammaly is a pet health startup that develops snacks to ease the severity of aging issues in dogs. | Health care | Cologne, Germany | Series A | $15.0M | 2023-09-13 | IRIS Ventures, Five Seasons Ventures | 51 to 100 | 2020 | |
| NewBiologix | NewBiologix is a technology innovation company. | Biotech | Epalinges, Switzerland | Series A | $50.3M | 2023-05-11 | $50.3M | Recipharm Venture Fund | 11 to 50 | 2023 |
| anvajo | anvajo is a Dresden-based company that develops, manufactures and sells liquid analysis solutions. | Biotech | Dresden, Germany | Series A | $17.3M | 2022-10-19 | Think.Health, Die Brückenköpfe, Johnsonville Ventures | 51 to 100 | 2016 | |
| Sympatient | Sympatient provides an operating system for psychotherapy that combines care structures and technology within regulated healthcare. | Fintech | Hamburg, Germany | Series A | $7.4M | 2022-09-29 | Verve Ventures, Kinled Holding, Investitions- und Förderbank | 51 to 100 | 2017 | |
| PeakData | PeakData provides a software platform that identifies and analyzes key opinion leaders in a therapeutic area. | Artificial intelligence | Zug, Switzerland | Series A | $12.4M | 2022-08-22 | Octopus Ventures, AlbionVC, Heal Capital | 51 to 100 | 2017 | |
| Cara Care | Cara Care offers an app-based treatment for patients with chronic gastrointestinal problems. | Health care | Hamburg, Germany | Series A | $7.0M | 2022-06-13 | $16.0M | Atlantic, Johnson & Johnson Innovation | 11 to 50 | 2016 |
| CDR-Life AG | CDR-Life AG develops therapeutic antibody fragments for immuno-oncology. | Biotech | Schlieren, Switzerland | Series A | $76.0M | 2022-04-13 | $76.0M | RA Capital Management, Omega Funds, Jeito Capital | 51 to 100 | 2017 |
Table 1. Health care startups that raised Series A in DACH: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 240.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 2 | nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| 3 | Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich, Switzerland | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| 4 | mbiomics | mbiomics is a biotechnology company. | Biotech | Munich, Germany | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| 5 | RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg, Germany | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| 6 | Altavo | Altavo develops medical devices as a startup. | Health care | Dresden, Germany | Series A | $3.5M | 2026-01-22 | $8.9M | HTGF (High-Tech Gruenderfonds), TGFS - Technologiegründerfonds Sachsen, bm-t beteiligungsmanagement thuringen +2 | 11 to 50 | 2021 |
| 7 | SOMAREALITY | SOMAREALITY develops spatial computing and eye tracking technology to measure cognitive digital biomarkers. | Education | Vienna, Austria | Series A | $3.4M | 2026-06-18 | $8.4M | Startup Wise Guys, The Austrian Research Promotion Agency (FFG), Gateway Ventures +2 | 11 to 50 | 2019 |
| 8 | Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
Table 2. Health care startups that raised Series A in DACH: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 21 | 9% | 3 | mbiomics, RAYDIAX, Altavo |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | 12 | 5% | ||
| 3 | Bayern Kapital | Venture capital firm | Landshut, Germany | 7 | 3% | 1 | mbiomics |
| 4 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 5 | 2% | ||
| 5 | KfW | Government investment office | Frankfurt, Germany | 5 | 2% | ||
| 6 | Fraunhofer Venture | Venture capital firm | Munich, Germany | 4 | 2% | 1 | Cellbox Solutions |
| 7 | Speedinvest | Venture capital firm | Vienna, Austria | 4 | 2% | 1 | Rivia |
| 8 | Verve Ventures | Venture capital firm | Zug, Switzerland | 4 | 2% | ||
| 9 | Innosuisse | Government investment office | Berne, Switzerland | 4 | 2% | ||
| 10 | APEX Ventures | Venture capital firm | Vienna, Austria | 4 | 2% | ||
| 11 | BioMedPartners | Venture capital firm | Basel, Switzerland | 4 | 2% | ||
| 12 | IBB Ventures | Venture capital firm | Berlin, Germany | 3 | 1% | 1 | Ascléa |
| 13 | Nina Capital | Micro VC fund | Barcelona, Spain | 3 | 1% | 1 | Rivia |
| 14 | Wellington Partners | Venture capital firm | Munich, Germany | 3 | 1% | 1 | nyra health |
| 15 | Plug and Play | Startup accelerator | Sunnyvale, United States | 3 | 1% |
Table 3. Health care startups that raised Series A in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series A in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 240 | 100% | $6.6M |
Table 5. Health care startups that raised Series A in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Germany | 129 | 54% |
| Switzerland | 89 | 37% |
| Austria | 21 | 9% |
| Liechtenstein | 1 | 0% |
Table 6. Health care startups that raised Series A in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Berlin | 39 | 16% |
| Munich | 17 | 7% |
| Vienna | 15 | 6% |
| Basel | 14 | 6% |
| Zürich | 13 | 5% |
| Lausanne | 13 | 5% |
| Hamburg | 11 | 5% |
| Epalinges | 6 | 2% |
| Schlieren | 6 | 2% |
| Cologne | 4 | 2% |
| Geneva | 4 | 2% |
| Martinsried | 4 | 2% |
Table 7. Health care startups that raised Series A in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 12% | $6.5M |
| September 2026 | 1 | 6% | $13.7M |
| July 2026 | 1 | 6% | |
| June 2026 | 2 | 12% | $8.7M |
| April 2026 | 1 | 6% | $12.0M |
| March 2026 | 3 | 19% | $27.8M |
| February 2026 | 3 | 19% | $53.6M |
| January 2026 | 2 | 12% | $32.3M |
| December 2025 | 1 | 6% | $20.0M |
Table 8. Health care startups that raised Series A in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 15 | 6% | $154.7M |
| 2025 | 17 | 7% | $228.0M |
| 2024 | 29 | 12% | $373.2M |
| 2023 | 19 | 8% | $204.2M |
| 2022 | 19 | 8% | $303.8M |
| 2021 | 27 | 11% | $316.2M |
Table 9. Health care startups that raised Series A in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 1% |
| 2020 to 2022 | 33 | 14% |
| 2015 to 2019 | 109 | 46% |
| 2010 to 2014 | 61 | 26% |
| Before 2010 | 33 | 14% |
Table 10. Health care startups that raised Series A in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 70 | 29% |
| 11 to 50 | 124 | 52% |
| 51 to 100 | 29 | 12% |
| 101 to 250 | 9 | 4% |
| 251 to 500 | 4 | 2% |
| 501 to 1,000 | 1 | 0% |
| 1,001 to 5,000 | 1 | 0% |
Table 11. Health care startups that raised Series A in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in DACH. On 16 November 2026 that is 240 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 240 rows: 60 have no round amount, 0 no city and 88 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in DACH whose last round is Series A are on the list?
- 240, in the file dated 16 November 2026. 16 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 240 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.